Springer Nature
Browse
12902_2021_797_MOESM1_ESM.pdf (196.47 kB)

Additional file 1 of Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies

Download (196.47 kB)
journal contribution
posted on 2021-06-27, 03:17 authored by Bin Sun, Nilanjan Sengupta, Anita Rao, Charles Donnelly, Vinit Waichale, Arnab Sinha Roy, Shilpa Ramaswamy, Divya Pathak, Ronald R. Bowsher, Yaron Raiter, Patrick Aubonnet, Abhijit Barve
Additional file 1. List of IRBs and ECs

Funding

Viatris, Inc Biocon

History

Usage metrics

    BMC Endocrine Disorders

    Categories

    Keywords

    BiosimilarDiabetes mellitusImmunogenicityInsulin glargineMYL-1501D

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC